Journal ArticleJMIR Res Protoc · September 24, 2024
BACKGROUND: Although the incidence of acute myocardial infarction (AMI) is rising in sub-Saharan Africa, the uptake of evidence-based care for the diagnosis and treatment of AMI is limited throughout the region. In Tanzania, studies have revealed common mi ...
Full textLink to itemCite
Journal ArticleJACC Adv · September 2024
BACKGROUND: Coronary plaque is common among people with HIV (PWH) with low-to-moderate traditional atherosclerotic cardiovascular disease (ASCVD) risk. OBJECTIVES: The purpose of this study was to determine the association of high-sensitivity cardiac tropo ...
Full textLink to itemCite
Journal ArticleAm Heart J · August 29, 2024
BACKGROUND: Hypertension is a leading risk factor for cardiovascular disease among patients living with HIV (PLWH). Understanding the predictors and patterns of antihypertensive medication prescription and blood pressure (BP) control among PLWH with hypert ...
Full textLink to itemCite
Journal ArticlemedRxiv · August 9, 2024
BACKGROUND: People with HIV (PWH) are at elevated risk for atherosclerotic cardiovascular disease (ASCVD). Underrepresented racial and ethnic groups (UREGs) with HIV in the southern U.S. are disproportionately affected, yet whether cardiology specialist ca ...
Full textLink to itemCite
Journal ArticleLancet Glob Health · August 2024
BACKGROUND: The Bridging Income Generation with Group Integrated Care (BIGPIC) trial in rural Kenya showed that integrating usual care with group medical visits or microfinance interventions reduced systolic blood pressure and cardiovascular risk in partic ...
Full textLink to itemCite
Journal ArticleJ Racial Ethn Health Disparities · June 2024
BACKGROUND: Underrepresented racial and ethnic groups (UREGs) with HIV have a higher risk of cardiovascular disease (CVD) compared with the general population. Referral to a cardiovascular specialist improves CVD risk factor management in high-risk individ ...
Full textLink to itemCite
Journal ArticleAIDS · June 1, 2024
People with HIV are at increased risk of cardiac dysfunction; however, limited tools are available to identify patients at highest risk for future cardiac disease. We performed proteomic profiling using plasma samples from children and young adults with pe ...
Full textLink to itemCite
Journal ArticleJACC Adv · June 2024
BACKGROUND: People with HIV (PWH) have a high burden of coronary plaques; however, the comparison to people without known HIV (PwoH) needs clarification. OBJECTIVES: The purpose of this study was to determine coronary plaque burden/phenotype in PWH vs PwoH ...
Full textLink to itemCite
Journal ArticleAIDS Patient Care STDS · June 2024
The increased incidence of chronic diseases among people with HIV (PWH) is poised to increase the need for specialty care outside of HIV treatment settings. To reduce outcome disparities for HIV-associated comorbidities in the United States, it is critical ...
Full textLink to itemCite
Journal ArticleJAMA Netw Open · May 1, 2024
IMPORTANCE: Clinical outcomes after acute coronary syndromes (ACS) or percutaneous coronary interventions (PCIs) in people living with HIV have not been characterized in sufficient detail, and extant data have not been synthesized adequately. OBJECTIVE: To ...
Full textLink to itemCite
Journal ArticleJAMA Cardiol · April 1, 2024
IMPORTANCE: Cardiovascular disease (CVD) is increased in people with HIV (PWH) and is characterized by premature noncalcified coronary plaque. In the Randomized Trial to Prevent Vascular Events in HIV (REPRIEVE), pitavastatin reduced major adverse cardiova ...
Full textLink to itemCite
Journal ArticleAIDS Res Ther · March 4, 2024
BACKGROUND: Cardiovascular disease (CVD) remains a leading cause of death in people living with HIV. Myocardial fibrosis is well-described in HIV infection acquired in adulthood. We evaluate the burden of fibrosis by cardiac magnetic resonance in people wi ...
Full textLink to itemCite
Journal ArticleJAMA Netw Open · March 4, 2024
IMPORTANCE: Despite higher atherosclerotic cardiovascular disease (ASCVD) risk, people with HIV (PWH) experience unique barriers to ASCVD prevention, such as changing models of HIV primary care. OBJECTIVE: To test whether a multicomponent nurse-led strateg ...
Full textOpen AccessLink to itemCite
Journal ArticlePsychiatry Res · March 2024
The Patient Health Questionnaire 9 (PHQ-9) is the current standard outpatient screening tool for measuring and tracking the nine symptoms of major depressive disorder (MDD). While the PHQ-9 was originally conceptualized as a unidimensional measure, it has ...
Full textLink to itemCite
Journal ArticleBlood Adv · February 27, 2024
Clonal hematopoiesis of indeterminate potential (CHIP), the clonal expansion of myeloid cells with leukemogenic mutations, results in increased coronary artery disease (CAD) risk. CHIP is more prevalent among people with HIV (PWH), but the risk factors are ...
Full textOpen AccessLink to itemCite
Journal ArticleCirc Cardiovasc Imaging · February 2024
Achieving optimal cardiovascular health in rural populations can be challenging for several reasons including decreased access to care with limited availability of imaging modalities, specialist physicians, and other important health care team members. The ...
Full textLink to itemCite
Journal ArticleJMIR Res Protoc · September 24, 2024
BACKGROUND: Although the incidence of acute myocardial infarction (AMI) is rising in sub-Saharan Africa, the uptake of evidence-based care for the diagnosis and treatment of AMI is limited throughout the region. In Tanzania, studies have revealed common mi ...
Full textLink to itemCite
Journal ArticleJACC Adv · September 2024
BACKGROUND: Coronary plaque is common among people with HIV (PWH) with low-to-moderate traditional atherosclerotic cardiovascular disease (ASCVD) risk. OBJECTIVES: The purpose of this study was to determine the association of high-sensitivity cardiac tropo ...
Full textLink to itemCite
Journal ArticleAm Heart J · August 29, 2024
BACKGROUND: Hypertension is a leading risk factor for cardiovascular disease among patients living with HIV (PLWH). Understanding the predictors and patterns of antihypertensive medication prescription and blood pressure (BP) control among PLWH with hypert ...
Full textLink to itemCite
Journal ArticlemedRxiv · August 9, 2024
BACKGROUND: People with HIV (PWH) are at elevated risk for atherosclerotic cardiovascular disease (ASCVD). Underrepresented racial and ethnic groups (UREGs) with HIV in the southern U.S. are disproportionately affected, yet whether cardiology specialist ca ...
Full textLink to itemCite
Journal ArticleLancet Glob Health · August 2024
BACKGROUND: The Bridging Income Generation with Group Integrated Care (BIGPIC) trial in rural Kenya showed that integrating usual care with group medical visits or microfinance interventions reduced systolic blood pressure and cardiovascular risk in partic ...
Full textLink to itemCite
Journal ArticleJ Racial Ethn Health Disparities · June 2024
BACKGROUND: Underrepresented racial and ethnic groups (UREGs) with HIV have a higher risk of cardiovascular disease (CVD) compared with the general population. Referral to a cardiovascular specialist improves CVD risk factor management in high-risk individ ...
Full textLink to itemCite
Journal ArticleAIDS · June 1, 2024
People with HIV are at increased risk of cardiac dysfunction; however, limited tools are available to identify patients at highest risk for future cardiac disease. We performed proteomic profiling using plasma samples from children and young adults with pe ...
Full textLink to itemCite
Journal ArticleJACC Adv · June 2024
BACKGROUND: People with HIV (PWH) have a high burden of coronary plaques; however, the comparison to people without known HIV (PwoH) needs clarification. OBJECTIVES: The purpose of this study was to determine coronary plaque burden/phenotype in PWH vs PwoH ...
Full textLink to itemCite
Journal ArticleAIDS Patient Care STDS · June 2024
The increased incidence of chronic diseases among people with HIV (PWH) is poised to increase the need for specialty care outside of HIV treatment settings. To reduce outcome disparities for HIV-associated comorbidities in the United States, it is critical ...
Full textLink to itemCite
Journal ArticleJAMA Netw Open · May 1, 2024
IMPORTANCE: Clinical outcomes after acute coronary syndromes (ACS) or percutaneous coronary interventions (PCIs) in people living with HIV have not been characterized in sufficient detail, and extant data have not been synthesized adequately. OBJECTIVE: To ...
Full textLink to itemCite
Journal ArticleJAMA Cardiol · April 1, 2024
IMPORTANCE: Cardiovascular disease (CVD) is increased in people with HIV (PWH) and is characterized by premature noncalcified coronary plaque. In the Randomized Trial to Prevent Vascular Events in HIV (REPRIEVE), pitavastatin reduced major adverse cardiova ...
Full textLink to itemCite
Journal ArticleAIDS Res Ther · March 4, 2024
BACKGROUND: Cardiovascular disease (CVD) remains a leading cause of death in people living with HIV. Myocardial fibrosis is well-described in HIV infection acquired in adulthood. We evaluate the burden of fibrosis by cardiac magnetic resonance in people wi ...
Full textLink to itemCite
Journal ArticleJAMA Netw Open · March 4, 2024
IMPORTANCE: Despite higher atherosclerotic cardiovascular disease (ASCVD) risk, people with HIV (PWH) experience unique barriers to ASCVD prevention, such as changing models of HIV primary care. OBJECTIVE: To test whether a multicomponent nurse-led strateg ...
Full textOpen AccessLink to itemCite
Journal ArticlePsychiatry Res · March 2024
The Patient Health Questionnaire 9 (PHQ-9) is the current standard outpatient screening tool for measuring and tracking the nine symptoms of major depressive disorder (MDD). While the PHQ-9 was originally conceptualized as a unidimensional measure, it has ...
Full textLink to itemCite
Journal ArticleBlood Adv · February 27, 2024
Clonal hematopoiesis of indeterminate potential (CHIP), the clonal expansion of myeloid cells with leukemogenic mutations, results in increased coronary artery disease (CAD) risk. CHIP is more prevalent among people with HIV (PWH), but the risk factors are ...
Full textOpen AccessLink to itemCite
Journal ArticleCirc Cardiovasc Imaging · February 2024
Achieving optimal cardiovascular health in rural populations can be challenging for several reasons including decreased access to care with limited availability of imaging modalities, specialist physicians, and other important health care team members. The ...
Full textLink to itemCite
Journal ArticleAnn Glob Health · 2024
BACKGROUND: Uptake of evidence-based care for acute myocardial infarction (AMI) is suboptimal in Tanzania, but there are currently no published interventions to improve AMI care in sub-Saharan Africa. OBJECTIVES: Co-design a quality improvement interventio ...
Full textLink to itemCite
Journal ArticlePLoS One · 2024
BACKGROUND: Chronic myocardial injury is a condition defined by stably elevated cardiac biomarkers without acute myocardial ischemia. Although studies from high-income countries have reported that chronic myocardial injury predicts adverse prognosis, there ...
Full textLink to itemCite
Journal ArticleClin Infect Dis · December 15, 2023
BACKGROUND: Pericoronary adipose tissue (PCAT) may influence plaque development through inflammatory mechanisms. We assessed PCAT density, as a measure of pericoronary inflammation, in relationship to coronary plaque among people with human immunodeficienc ...
Full textLink to itemCite
Journal ArticleBMJ Open · November 19, 2023
OBJECTIVES: We aimed to prospectively describe incident cardiovascular events among people living with HIV (PLWH) in northern Tanzania. Secondary aims of this study were to understand non-communicable disease care-seeking behaviour and patient preferences ...
Full textLink to itemCite
Journal ArticleJ Card Fail · November 2023
BACKGROUND: Clinical and echocardiographic features may carry diverse information about the development of heart failure (HF). Therefore, we determined heterogeneity in clinical and echocardiographic phenotypes and its association with exercise capacity. M ...
Full textLink to itemCite
Journal ArticleOpen Forum Infect Dis · October 2023
Plasma vascular endothelial growth factor (VEGF) coreceptor neuropilin-1 (NRP-1) had the largest association with coronary plaque in the Randomized Trial to Prevent Vascular Events in HIV (REPRIEVE) proteomics analysis. With little known about NRP-1 in peo ...
Full textLink to itemCite
Journal ArticleRes Sq · September 26, 2023
BACKGROUND: Cardiovascular disease (CVD) remains a leading cause of death in people living with HIV. Myocardial fibrosis is well-described in HIV infection acquired in adulthood. We evaluate the burden of fibrosis by cardiac magnetic resonance in people wi ...
Full textLink to itemCite
Journal ArticleN Engl J Med · August 24, 2023
BACKGROUND: The risk of cardiovascular disease is increased among persons with human immunodeficiency virus (HIV) infection, so data regarding primary prevention strategies in this population are needed. METHODS: In this phase 3 trial, we randomly assigned ...
Full textLink to itemCite
Journal ArticleBMC Health Serv Res · August 11, 2023
BACKGROUND: Hypertension is the leading cause of death and disability. Clinical care for patients with hypertension in Kenya leverages referral networks to provide basic and specialized healthcare services. However, referrals are characterized by non-adher ...
Full textLink to itemCite
Journal ArticleAIDS · March 1, 2023
OBJECTIVE: To investigate relationships between Life's Simple 7 (LS7), an assessment of cardiovascular health (CVH), and coronary plaque among people with HIV (PWH). DESIGN: Cross-sectional. METHODS: Coronary computed tomography angiography, immune/inflamm ...
Full textLink to itemCite
Journal ArticleClin Infect Dis · February 8, 2023
BACKGROUND: Cytomegalovirus (CMV) infection is thought to result in increased immune activation in people with human immunodeficiency virus (HIV, PWH). Although some data have linked asymptomatic CMV infection to cardiovascular disease among PWH, it remain ...
Full textLink to itemCite
Journal ArticleJAMA Cardiol · February 1, 2023
IMPORTANCE: Extant data on the performance of cardiovascular disease (CVD) risk score models in people living with HIV have not been synthesized. OBJECTIVE: To synthesize available data on the performance of the various CVD risk scores in people living wit ...
Full textLink to itemCite
Journal ArticleClin Infect Dis · January 13, 2023
BACKGROUND: Among people with HIV (PWH), sex differences in presentations of atherosclerotic cardiovascular disease (ASCVD) may be influenced by differences in coronary plaque parameters, immune/inflammatory biomarkers, or relationships therein. METHODS: R ...
Full textLink to itemCite
Journal ArticlePLOS Glob Public Health · 2023
The prevalence of cardiovascular disease (CVD) is rising among people with HIV (PWH) in sub-Saharan Africa (SSA). Despite the utility of the electrocardiogram (ECG) in screening for CVD, there is limited data regarding longitudinal ECG changes among PWH in ...
Full textLink to itemCite
Journal ArticleBMJ Open · December 19, 2022
INTRODUCTION: Most of the global non-communicable disease (NCD)-related death burden is borne by low and middle-income countries (LMICs). In LMICs like Pakistan, however, a major gap in responding to NCDs is a lack of high-quality research leading to polic ...
Full textLink to itemCite
Journal ArticleGlob Public Health · December 2022
HIV is associated with increased risk of cardiovascular disease, but there has been less study of cardiovascular comorbidities among people with HIV in sub-Saharan Africa. In a cross-sectional observational study, Tanzanian adults presenting for outpatient ...
Full textLink to itemCite
Journal ArticleInt J Cardiol Cardiovasc Risk Prev · December 2022
Coomprhensive data on temporal trends in cardiovascular disease (CVD) risk factors and outcomes in people living with HIV are limited. Using retrospective data on 50,284 US Veterans living with HIV (VLWH) who received care in the VA from 2001 to 2019, we c ...
Full textLink to itemCite
Journal ArticleAIDS · November 15, 2022
OBJECTIVE: To characterize diet quality across a global cohort of people with HIV (PWH). DESIGN: Cross-sectional analysis. METHODS: Leveraging REPRIEVE data from baseline across five Global Burden of Disease (GBD) regions, we analyzed participant responses ...
Full textLink to itemCite
Journal ArticleJ Infect Dis · November 11, 2022
BACKGROUND: People with HIV (PWH) have subclinical coronary artery disease (CAD) despite low traditional atherosclerotic cardiovascular disease (ASCVD) risk scores. Coronary plaque in PWH presents as a unique phenotype, but little is known about the contri ...
Full textLink to itemCite
Journal ArticleClin Infect Dis · October 12, 2022
BACKGROUND: Among antiretroviral therapy (ART)-treated people with human immunodeficiency virus (PWH), persistent systemic immune activation contributes to atherogenesis atherosclerotic, cardiovascular disease (CVD) events, and mortality. Factors associate ...
Full textLink to itemCite
Journal ArticleClin Infect Dis · September 30, 2022
BACKGROUND: We sought to explore multinational differences in functional status by global burden of disease (GBD) regions in the REPRIEVE cohort. METHODS: REPRIEVE is a prospective, double-blind, randomized, placebo-controlled, multicenter, phase III prima ...
Full textLink to itemCite
Journal ArticleJ Acquir Immune Defic Syndr · August 1, 2022
BACKGROUND: Limited data are available regarding asymptomatic COVID-19 among people with HIV (PWH). Data on a representative subset of PWH enrolled in Randomized Trial to Prevent Vascular Events in HIV, a global clinical trial, are presented here. METHODS: ...
Full textLink to itemCite
Journal ArticleBMC Health Serv Res · May 9, 2022
BACKGROUND: Cardiology care may be beneficial for risk factor management in people living with HIV (PLWH), yet limited information is available about the referral process from the perspectives of HIV specialists and cardiologists. METHODS: We conducted 28 ...
Full textLink to itemCite
Journal ArticleContemp Clin Trials · May 2022
BACKGROUND: Improving diversity in clinical trials is essential in order to produce generalizable results. Although the importance of representation has become increasingly recognized, identifying strategies to approach this work remains elusive. This arti ...
Full textLink to itemCite
Journal ArticleCirculation. Cardiovascular quality and outcomes · April 2022
BackgroundLittle is known about long-term outcomes and uptake of secondary preventative therapies following acute myocardial infarction (AMI) in sub-Saharan Africa.MethodsConsecutive patients presenting with AMI (as defined by the Fourth ...
Full textCite
Journal ArticleBMC Health Serv Res · March 7, 2022
BACKGROUND: Health system approaches to improve hypertension control require an effective referral network. A national referral strategy exists in Kenya; however, a number of barriers to referral completion persist. This paper is a baseline assessment of a ...
Full textLink to itemCite
Journal ArticleJ Acquir Immune Defic Syndr · March 1, 2022
BACKGROUND: People with HIV (PWH) are at increased risk of cardiovasvular disease (CVD) and sudden cardiac death. Previous work has suggested an association between HIV infection and electrocardiographic (ECG) abnormalities. There are limited data on the b ...
Full textLink to itemCite
Journal ArticleEchocardiography · February 2022
OBJECTIVE: People living with HIV (PLWH) are at increased risk for cardiac dysfunction. It is unknown how their global longitudinal cardiac function, cardiac structure, and other indices of function progress over time. We aimed to characterize the longitud ...
Full textLink to itemCite
Journal ArticleOpen Heart · January 21, 2022
Objectives Diastolic dysfunction (DD) has been reported to be highly prevalent in people living with HIV (PLWH) on antiretroviral therapy (ART) leading to the hypothesis that it may be an early marker of myocardial disease. Our objective was to evaluate th ...
Full textCite
Journal ArticleAnn Glob Health · 2022
BACKGROUND: Heart failure (HF), is a leading cause of cardiovascular morbidity and mortality in Sub-Saharan Africa. Cardiac rehabilitation (CR) is known to improve functional capacity and reduce morbidity associated with HF. Although CR is a low-cost inter ...
Full textLink to itemCite
Journal ArticleGlob Heart · 2022
INTRODUCTION: HIV confers increased risk of myocardial infarction (MI), but there has been little study of ischemic electrocardiogram (ECG) findings among people with HIV in sub-Saharan Africa. OBJECTIVES: To compare the prevalence of ischemic ECG findings ...
Full textLink to itemCite
Journal ArticleJ Cardiovasc Comput Tomogr · 2022
BACKGROUND: Coronary artery calcium (CAC) and left ventricular diastolic dysfunction (LVDD) are strong predictors of cardiovascular events and share common risk factors. However, their independent association remains unclear. METHODS: In the Project Baseli ...
Full textLink to itemCite
Journal ArticleGlob Heart · 2022
BACKGROUND AND OBJECTIVE: Few data exist on trends in acute myocardial infarction (AMI) patterns spanning recent epidemiological shifts in low middle-income countries (LMICs). To understand temporal disease patterns of AMI characteristics and outcomes betw ...
Full textLink to itemCite
Journal ArticleClin Infect Dis · December 6, 2021
BACKGROUND: In addition to traditional cardiovascular (CV) risk factors, antiretroviral therapy, lifestyle, and human immunodeficiency virus (HIV)-related factors may contribute to future CV events in persons with HIV (PWH). METHODS: Among participants in ...
Full textLink to itemCite
Journal ArticleAfrican journal of emergency medicine : Revue africaine de la medecine d'urgence · December 2021
IntroductionData describing atrial fibrillation (AF) care in emergency centres (ECs) in sub-Saharan Africa is lacking. We sought to describe the prevalence and outcomes of AF in a Tanzanian EC.MethodsIn a prospective, observational study, ...
Full textOpen AccessCite
Journal ArticleInt J Cardiol · November 1, 2021
OBJECTIVE: There is a rising burden of myocardial infarction (MI) within sub-Saharan Africa. Prospective studies of detailed MI outcomes in the region are lacking. METHODS: Adult patients with confirmed MI from a prospective surveillance study in northern ...
Full textLink to itemCite
Journal ArticleMedicine (Baltimore) · October 8, 2021
Despite the anticipated growth in the global burden of obesity especially in low-income countries, limited data exist on the contribution of obesity to cardiometabolic diseases in Africa.We examined population-based samples of Kenyan adults who participate ...
Full textLink to itemCite
Journal ArticleBMC Health Serv Res · September 3, 2021
BACKGROUND: Human-centered design (HCD) is an increasingly recognized approach for engaging stakeholders and developing contextually appropriate health interventions. As a component of the ongoing STRENGTHS study (Strengthening Referral Networks for Manage ...
Full textLink to itemCite
Journal ArticleBMJ Open · September 2, 2021
OBJECTIVES: Management of cardiovascular disease (CVD) is an urgent challenge in low-income and middle-income countries, and interventions may require appraisal of patients' social networks to guide implementation. The purpose of this study is to determine ...
Full textLink to itemCite
Journal ArticleJ Am Heart Assoc · August 3, 2021
Background Rigorous incidence data for acute myocardial infarction (AMI) in sub-Saharan Africa are lacking. Consequently, modeling studies based on limited data have suggested that the burden of AMI and AMI-associated mortality in sub-Saharan Africa is low ...
Full textOpen AccessLink to itemCite
Journal ArticleJ Am Coll Cardiol · April 27, 2021
BACKGROUND: Incorporating social determinants of health into care delivery for chronic diseases is a priority. OBJECTIVES: The goal of this study was to evaluate the impact of group medical visits and/or microfinance on blood pressure reduction. METHODS: T ...
Full textLink to itemCite
ConferenceStroke · March 2021
Background:
Mobile Cardiac outpatient telemetry (MCOT) is often used for patients (pts) with cryptogenic ischemic stroke following hospital discharge to detect atrial fibrillation (AFib) but criteria ...
Full textCite
Journal ArticleGlob Heart · February 9, 2021
BACKGROUND: Rheumatic heart disease (RHD) in sub-Saharan Africa contributes to significant cardiac morbidity and mortality, yet prevalence estimates of RHD lesions in pregnancy are lacking. OBJECTIVES: Our first aim was to evaluate women using echocardiogr ...
Full textLink to itemCite
Journal ArticleGlob Heart · January 18, 2021
BACKGROUND: Cardiovascular disease (CVD) is the leading cause of death and disability worldwide. Health research is crucial to managing disease burden. Previous work has highlighted marked discrepancies in research output and disease burden between high-in ...
Full textLink to itemCite
Journal ArticleAsia Pac J Public Health · January 2021
Hypertension is highly prevalent, but its pharmacological management has not been well evaluated in low- and middle-income countries (LMICs). This review examined the prescribing patterns of antihypertensives in LMICs. Data were extracted from a total of 2 ...
Full textLink to itemCite
Journal ArticleAIDS · January 1, 2021
INTRODUCTION: Markers of monocyte/macrophage activation and vascular inflammation are associated with HIV-related cardiovascular diseases (CVD) and mortality. We compared these markers among African people living with HIV (PLWH) and HIV-negative adults, an ...
Full textLink to itemCite
Journal ArticlePLoS One · 2021
BACKGROUND: Non-communicable diseases (NCDs) are the leading cause of mortality in the world, and innovative approaches to NCD care delivery are being actively developed and evaluated. Combining the group-based experience of microfinance and group medical ...
Full textLink to itemCite
Journal ArticlePLoS One · 2021
BACKGROUND: The burden of heart failure is growing in sub-Saharan Africa, but there is a dearth of data characterizing care and outcomes of heart failure patients in the region, particularly in emergency department settings. METHODS: In a prospective obser ...
Full textOpen AccessLink to itemCite
Journal ArticleAfrican Journal of Emergency Medicine · September 1, 2020
Background: In low- and middle-income countries (LMICs) where echocardiography experts are in short supply, training non-cardiologists to perform Focused Cardiac Ultrasound (FoCUS) could minimise diagnostic delays in time-critical emergencies. Despite advo ...
Full textCite
Journal ArticleOpen Forum Infect Dis · September 2020
BACKGROUND: The impact of clinician specialty on cardiovascular disease risk factor outcomes among persons with HIV (PWH) is unclear. METHODS: PWH receiving care at 3 Southeastern US academic HIV clinics between January 2014 and December 2016 were retrospe ...
Full textOpen AccessLink to itemCite
Journal ArticleJ Am Heart Assoc · August 18, 2020
Background Evidence suggests that acute coronary syndrome (ACS) is underdiagnosed in sub-Saharan Africa. Triage-based interventions have improved ACS diagnosis and management in high-income settings but have not been evaluated in sub-Saharan African emerge ...
Full textLink to itemCite
Journal ArticleBMC Health Serv Res · August 12, 2020
An amendment to this paper has been published and can be accessed via the original article. ...
Full textLink to itemCite
Journal ArticleAm Heart J · August 2020
BACKGROUND: Growing evidence suggests that under-diagnosis of acute myocardial infarction (AMI) may be common in sub-Saharan Africa. Prospective studies of routine AMI screening among patients presenting to emergency departments in sub-Saharan Africa are l ...
Full textOpen AccessLink to itemCite
Journal ArticleJ Infect Dis · July 9, 2020
BACKGROUND: People with human immunodeficiency virus (PWH) face increased risks for heart failure and adverse heart failure outcomes. Myocardial steatosis predisposes to diastolic dysfunction, a heart failure precursor. We aimed to characterize myocardial ...
Full textLink to itemCite
Journal ArticleJ Infect Dis · July 9, 2020
BACKGROUND: Patterns of antiretroviral therapy (ART) use and immunologic correlates vary globally, and contemporary trends are not well described. METHODS: The REPRIEVE trial (Randomized Trial to Prevent Vascular Events in HIV) enrolled persons with human ...
Full textLink to itemCite
Journal ArticleJACC Heart Fail · June 2020
OBJECTIVES: This study sought to investigate outcomes of heart failure (HF) in veterans living with human immunodeficiency virus (HIV). BACKGROUND: Data on outcomes of HF among people living with human immunodeficiency virus (PLHIV) are limited. METHODS: W ...
Full textLink to itemCite
Journal ArticleBMC Health Serv Res · May 12, 2020
BACKGROUND: Non-communicable disease (NCD) care in Sub-Saharan Africa is challenging due to barriers including poverty and insufficient health system resources. Local culture and context can impact the success of interventions and should be integrated earl ...
Full textLink to itemCite
Journal ArticleThe lancet. HIV · April 2020
HIV-related cardiovascular disease research is predominantly from Europe and North America. Of the estimated 37·9 million people living with HIV worldwide, 25·6 million live in sub-Saharan Africa. Although mechanisms for HIV-related cardiovascular disease ...
Full textCite
Journal ArticleAIDS · March 15, 2020
OBJECTIVE: To define the prevalence of early cardiac dysfunction in children and young adults with perinatally acquired HIV and predictors of cardiac function. DESIGN: Cross-sectional design. METHODS: Early cardiac dysfunction was defined as left ventricul ...
Full textLink to itemCite
Journal ArticleGlob Heart · February 7, 2020
BACKGROUND: Cardiac disease is a leading cause of non-obstetric maternal death worldwide, but little is known about its burden in sub-Saharan Africa. OBJECTIVES AND METHODS: We conducted a retrospective case-control study of pregnant women admitted to a na ...
Full textLink to itemCite
Journal ArticleGlob Heart · February 6, 2020
BACKGROUND: Acute coronary syndrome (ACS) is thought to be a rare diagnosis in sub-Saharan Africa, but little is known about diagnostic practices for patients with possible ACS symptoms in the region. OBJECTIVE: To describe current care practices for patie ...
Full textOpen AccessLink to itemCite
Journal ArticleProg Cardiovasc Dis · 2020
Despite developments to improve health in the United States, racial and ethnic disparities persist. These disparities have profound impact on the wellbeing of historically marginalized racial and ethnic groups. This narrative review explores disparities by ...
Full textLink to itemCite
Journal ArticleProg Cardiovasc Dis · 2020
As longevity has increased for people living with HIV (PLWH) in the United States and Europe, there has been a concomitant increase in the prevalence of cardiovascular disease (CVD) risk factors and morbidity in this population. Whereas the availability of ...
Full textLink to itemCite
Journal ArticleProg Cardiovasc Dis · 2020
Stakeholder-informed strategies addressing cardiovascular disease (CVD) burden among people living with HIV (PWH) are needed within healthcare settings. This study provides an assessment of how human-centered design (HCD) guided the adaptation of a nurse-l ...
Full textOpen AccessLink to itemCite
Journal ArticleJ Acquir Immune Defic Syndr · December 1, 2019
BACKGROUND: As the noncommunicable disease (NCD) burden is rising in regions with high HIV prevalence, patients with comorbid HIV and chronic NCDs may benefit from integrated chronic disease care. There are few evaluations of the effectiveness of such stra ...
Full textLink to itemCite
Journal ArticleJ Am Coll Cardiol · October 15, 2019
BACKGROUND: Elevated blood pressure (BP) is the leading global risk factor for mortality. Delay in seeking hypertension care is associated with increased mortality. OBJECTIVES: This study investigated whether community health workers, equipped with behavio ...
Full textLink to itemCite
Journal ArticleAm Heart J · October 2019
Persons living with human immunodeficiency virus (PLHIV) are at increased risk of atherosclerotic cardiovascular disease (ASCVD). In spite of this, uptake of evidence-based clinical interventions for ASCVD risk reduction in the HIV clinic setting is sub-op ...
Full textOpen AccessLink to itemCite
Journal ArticleLancet Gastroenterol Hepatol · October 2019
BACKGROUND: More than 70 million people worldwide are estimated to have hepatitis C virus (HCV) infection. Emerging evidence indicates an association between HCV and atherosclerotic cardiovascular disease. We aimed to determine the association between HCV ...
Full textLink to itemCite
Journal ArticleAm J Cardiol · September 15, 2019
Improvement in survival in patients living with human immunodeficiency virus (PLHIV) has led to increased prevalence of cardiovascular disease. Whether HIV-associated immune dysfunction is associated with preclinical left ventricular (LV) dysfunction despi ...
Full textLink to itemCite
Journal ArticleTrials · September 9, 2019
BACKGROUND: Hypertension is a major risk factor for cardiovascular disease (CVD), yet treatment and control rates for hypertension are very low in low- and middle-income countries (LMICs). Lack of effective referral networks between different levels of the ...
Full textLink to itemCite
Journal ArticleCirculation · July 9, 2019
As early and effective antiretroviral therapy has become more widespread, HIV has transitioned from a progressive, fatal disease to a chronic, manageable disease marked by elevated risk of chronic comorbid diseases, including cardiovascular diseases (CVDs) ...
Full textLink to itemCite
Journal ArticleHealth Aff (Millwood) · July 2019
Health systems in sub-Saharan Africa are facing an ongoing HIV epidemic and increasing burden of noncommunicable disease. With the focus shifting to the development of comprehensive primary health care and chronic disease treatment, multidisease modeling i ...
Full textLink to itemCite
Journal ArticleGlob Heart · June 2019
BACKGROUND: Ineffective referral networks in low- and middle-income countries hinders access to evidence-based therapies by hypertensive patients, leading to high cardiovascular mortality and morbidity. The STRENGTHS (Strengthening Referral Networks for Ma ...
Full textLink to itemCite
Journal ArticleAm Heart J · April 2019
BACKGROUND: Little is known about community knowledge of myocardial infarction symptoms and perceptions of self-risk in sub-Saharan Africa. METHODS: A community survey was conducted in northern Tanzania, where the prevalence of cardiovascular risk factors ...
Full textLink to itemCite
ConferenceCirculation · March 5, 2019
Background:
Heart failure (HF) is a growing driver of morbidity and mortality worldwide. Cardiac rehabilitation in HF improves functional status, quality of life, and depression. Global access to card ...
Full textCite
Journal ArticleAm J Cardiol · March 1, 2019
The introduction of transcatheter aortic valve implantation (TAVI) has revolutionized the treatment of patients with severe aortic stenosis (AS). However, despite the great clinical success of TAVI, less is known about the cardiac hemodynamics and structur ...
Full textLink to itemCite
Journal ArticleJACC Heart Fail · February 2019
OBJECTIVE: To synthesize existing epidemiological data on cardiac dysfunction in HIV. BACKGROUND: Data on the burden and risk of human immunodeficiency virus (HIV) infection-associated cardiac dysfunction have not been adequately synthesized. We performed ...
Full textLink to itemCite
Journal ArticlePLoS One · 2019
BACKGROUND: Little is known about community perceptions of chest pain and healthcare seeking behavior for chest pain in sub-Saharan Africa. METHODS: A two-stage randomized population-based cluster survey with selection proportional to population size was p ...
Full textLink to itemCite
Journal ArticleJ Am Heart Assoc · November 6, 2018
Background HIV is associated with elevated risk of heart failure ( HF ). Despite poor agreement between automated, administrative code-based HF definitions and physician-adjudicated HF , no studies have evaluated incident adjudicated HF for people living w ...
Full textLink to itemCite
Journal ArticleInt J Cardiovasc Imaging · November 2018
Quality in stress echocardiography interpretation is often gauged against coronary angiography (CA) data but anatomic obstructive coronary disease on CA is an imperfect gold standard for a stress induced wall motion abnormality. We examined the utility of ...
Full textLink to itemCite
Journal ArticleLancet · October 27, 2018
BACKGROUND: Glucagon-like peptide 1 receptor agonists differ in chemical structure, duration of action, and in their effects on clinical outcomes. The cardiovascular effects of once-weekly albiglutide in type 2 diabetes are unknown. We aimed to determine t ...
Full textLink to itemCite
Journal ArticleJ Card Fail · August 2018
OBJECTIVE: The aim of this work was to investigate determinants of structural myocardial abnormalities in persons living with human immunodeficiency virus (PLWH). METHODS AND RESULTS: We reviewed archived transthoracic echocardiograms (TTEs) performed on P ...
Full textLink to itemCite
Journal ArticleEast African Medical Journal · August 1, 2018
Objectives: Congenital heart disease (CHD) and rheumatic heart disease (RHD) are major health concerns among children in sub-Saharan Africa. Poverty is a key predictor of both conditions, but the mechanisms of that association are not well understood. Desi ...
Cite
Journal ArticleAIDS Patient Care STDS · June 2018
Metabolic syndrome (MetS), a cluster of cardiovascular disease risk factors, is increasingly common in people living with HIV; however, data on prevalence and the role of antiretroviral therapy (ART) as a risk factor for MetS in sub-Saharan Africa are lack ...
Full textLink to itemCite
Journal ArticlePLoS One · 2018
Elevated blood pressure presents a global health threat, with rates of hypertension increasing in low and middle-income countries. Lifestyle changes may be an important driver of these increases in blood pressure. Hypertension is particularly prevalent in ...
Full textLink to itemCite
Journal ArticleJ Diabetes Res · 2018
OBJECTIVE: To review available literature on the prevalence, risk factors, pathophysiology, and clinical outcomes of dysglycemia among people living with HIV (PLHIV) in sub-Saharan Africa (SSA). METHODS: Database search on PUBMED for eligible studies descr ...
Full textLink to itemCite
Journal ArticleCurr Opin HIV AIDS · November 2017
PURPOSE OF REVIEW: The current article addresses crucial issues in identifying risk of cardiovascular disease (CVD) in people living with HIV in low-income and middle-income countries (LMICs). These issues are in need of urgent attention to advance our kno ...
Full textLink to itemCite
Journal ArticleN Engl J Med · September 28, 2017
BACKGROUND: The cardiovascular effects of adding once-weekly treatment with exenatide to usual care in patients with type 2 diabetes are unknown. METHODS: We randomly assigned patients with type 2 diabetes, with or without previous cardiovascular disease, ...
Full textOpen AccessLink to itemCite
Journal ArticleAm Heart J · June 2017
BACKGROUND: Cardiovascular disease (CVD) is the leading cause of mortality worldwide, with >80% of CVD deaths occurring in low and middle income countries (LMICs). Diabetes mellitus and pre-diabetes are risk factors for CVD, and CVD is the major cause of m ...
Full textLink to itemCite
Journal ArticleGlobal Health · March 15, 2017
BACKGROUND: The imperative to improve global health has prompted transnational research partnerships to investigate common health issues on a larger scale. The Global Alliance for Chronic Diseases (GACD) is an alliance of national research funding agencies ...
Full textLink to itemCite
Journal ArticleCardiol Clin · February 2017
Cardiovascular diseases are approaching epidemic levels in Kenya and other low- and middle-income countries without accompanying effective preventive and therapeutic strategies. This is happening in the background of residual and emerging infections and ot ...
Full textLink to itemCite
Journal ArticleCardiol Clin · February 2017
Over the last 2 decades human immunodeficiency virus (HIV) infection has become a chronic disease requiring long-term management. Aging, antiretroviral therapy, chronic inflammation, and several other factors contribute to the increased risk of cardiovascu ...
Full textLink to itemCite
Journal ArticleOpen Heart · February 1, 2017
Objective Hypertension affects 23% of Kenyans and is the most prevalent modifiable risk factor for cardiovascular disease. Despite this, hypertension awareness and treatment adherence is very low. We conducted a qualitative study to explore lay beliefs abo ...
Full textCite
Journal ArticlePLoS One · 2017
BACKGROUND: Atrial fibrillation (AF) is a major contributor to the global cardiovascular disease burden. The clinical profile and outcomes of AF patients with valvular heart diseases in sub-Saharan Africa (SSA) have not been adequately described. We assess ...
Full textOpen AccessLink to itemCite
Journal ArticleInt J Cardiol · November 15, 2016
INTRODUCTION: Rheumatic heart disease (RHD) remains a leading cause of cardiovascular mortality in sub-Saharan Africa. Identifying high risk populations and geographic patterns of disease is crucial to developing RHD prevention and screening strategies in ...
Full textLink to itemCite
Journal ArticleCurr Cardiol Rep · November 2016
Effective combination antiretroviral therapy (ART) has enabled human immunodeficiency virus (HIV) infection to evolve from a generally fatal condition to a manageable chronic disease. This transition began two decades ago in high-income countries and has m ...
Full textLink to itemCite
Journal ArticleInt J Cardiol · October 1, 2016
BACKGROUND: The transition from association to causation could represent a fundamental step for taking preventive action against hypertension and its complications, especially among HIV-infected persons on antiretroviral therapy in sub-Saharan African coun ...
Full textLink to itemCite
Journal ArticleCurr Cardiol Rep · October 2016
Rheumatic heart disease (RHD) is a chronic valvular disease resulting after severe or repetitive episodes of acute rheumatic fever (ARF), an autoimmune response to group A Streptococcus infection. RHD has been almost eliminated with improved social and hea ...
Full textLink to itemCite
Journal ArticleJ Med Case Rep · May 25, 2016
BACKGROUND: Hereditary hemorrhagic telangiectasia is a rare autosomal dominant inherited disease characterized by vascular dysplasia. To the best of our knowledge, we report the first case in the literature of definite hereditary hemorrhagic telangiectasia ...
Full textLink to itemCite
Journal ArticleTrop Med Int Health · March 2016
OBJECTIVES: The prevalence of hyperlipidaemia, along with other non-communicable diseases, is on the rise in low- and middle-income countries. CardioChek PA is a point-of-care lipid measuring device, which seeks to overcome laboratory-based diagnostic barr ...
Full textLink to itemCite
Journal ArticleJ Gen Intern Med · March 2016
BACKGROUND: Hypertension, the leading global risk factor for mortality, is characterized by low treatment and control rates in low- and middle-income countries. Poor linkage to hypertension care contributes to poor outcomes for patients. However, specific ...
Full textLink to itemCite
Journal ArticleGlob Heart · March 2016
BACKGROUND: Cost-effective primary prevention of cardiovascular disease (CVD) in low- and middle-income countries requires accurate risk assessment. Laboratory-based risk tools currently used in high-income countries are relatively expensive and impractica ...
Full textLink to itemCite
Journal ArticleGlob Heart · March 2016
BACKGROUND: Hypertension is the leading cause of cardiovascular disease and premature death worldwide. The prevalence of this public health problem is increasing in low- and middle-income countries (LMICs) in both urban and rural communities. OBJECTIVE: Th ...
Full textLink to itemCite
Journal ArticleGlob Heart · March 2016
Stemming the tide of noncommunicable diseases (NCDs) worldwide requires a multipronged approach. Although much attention has been paid to disease control measures, there is relatively little consideration of the importance of training the next generation o ...
Full textLink to itemCite
Journal ArticleGlob Heart · March 2016
BACKGROUND: Although risk factors for heart failure are increasingly common worldwide, the contribution of atherosclerosis to heart failure in sub-Saharan Africa is largely unknown. OBJECTIVE: This study assessed the association between atherosclerotic ris ...
Full textLink to itemCite
Journal ArticleGlob Heart · March 2016
Effectively tackling the growing noncommunicable disease (NCD) burden in low- and middle-income countries (LMIC) is a major challenge. To address research needs in this setting for NCDs, in 2009, National Heart, Lung, and Blood Institute (NHLBI) and United ...
Full textLink to itemCite
Journal ArticleBiomed Res Int · 2016
Antiretroviral therapy (ART) has transformed the clinical profile of human immunodeficiency virus (HIV) from an acute infection with a high mortality into a treatable, chronic disease. As a result, the clinical sequelae of HIV infection are changing as pat ...
Full textLink to itemCite
Journal ArticleJ Am Coll Cardiol · December 8, 2015
Cardiovascular disease deaths are increasing in low- and middle-income countries and are exacerbated by health care systems that are ill-equipped to manage chronic diseases. Global health partnerships, which have stemmed the tide of infectious diseases in ...
Full textLink to itemCite
Journal ArticleGlob Heart · December 2015
Cardiovascular disease (CVD) is the leading cause of death in the world, with a substantial health and economic burden confronted by low- and middle-income countries. In low-income countries such as Kenya, there exists a double burden of communicable and n ...
Full textLink to itemCite
Journal ArticleEast African Medical Journal · December 1, 2015
In truncus arteriosus, the embryologic truncus fails to properly divide in-utero resulting in the pulmonary, aortic and coronary arteries arising from a single ascending portion of this trunk. This condition is usually fatal within the first year of life w ...
Cite
Journal ArticleImplement Sci · November 9, 2015
BACKGROUND: The Global Alliance for Chronic Diseases comprises the majority of the world's public research funding agencies. It is focussed on implementation research to tackle the burden of chronic diseases in low- and middle-income countries and amongst ...
Full textLink to itemCite
Journal ArticleBMC Infect Dis · October 14, 2015
BACKGROUND: Traditional cardiovascular disease (CVD) risk factors contribute to increase risk of CVD in people living with HIV (PLWH). Of all world regions, sub-Saharan Africa has the highest prevalence of HIV yet little is known about PLWH's CVD knowledge ...
Full textLink to itemCite
Journal ArticleAm Heart J · September 2015
BACKGROUND: There is an urgent need to understand genetic associations with atrial fibrillation in ethnically diverse populations. There are no such data from sub-Saharan Africa, despite the fact that atrial fibrillation is one of the fastest growing disea ...
Full textLink to itemCite
Journal ArticleJACC Heart Fail · August 2015
Successful combination therapy for human immunodeficiency virus (HIV) has transformed this disease from a short-lived infection with high mortality to a chronic disease associated with increasing life expectancy. This is true for high- as well as low- and ...
Full textLink to itemCite
Journal ArticleJ Am Heart Assoc · April 2, 2015
BACKGROUND: Cardiovascular research output and citations of publications from Africa have historically been low yet may be increasing. However, data from the continent are limited. METHODS AND RESULTS: To evaluate the cardiovascular research output and cit ...
Full textLink to itemCite
Journal ArticleGlob Heart · March 2015
Diabetes and hypertension are chronic conditions that are growing in prevalence as major causal factors of cardiovascular disease (CVD). The need for chronic-illness surveillance, population-risk management, and successful treatment interventions are cruci ...
Full textLink to itemCite
Journal ArticleArq Bras Cardiol · January 2015
BACKGROUND: Cardiovascular research publications seem to be increasing in Latin America overall. OBJECTIVE: To analyze trends in cardiovascular publications and their citations from countries in Latin America between 1999 and 2008, and to compare them with ...
Full textLink to itemCite
Journal ArticleJ Acquir Immune Defic Syndr · September 1, 2014
With the advent of effective antiretroviral therapy (ART), HIV is becoming a chronic disease. HIV-seropositive (+) patients on ART can expect to live longer and, as a result, they are at risk of developing chronic noncommunicable diseases related to factor ...
Full textLink to itemCite
Journal ArticleAm Heart J · August 2014
UNLABELLED: The introduction of transcatheter aortic valve replacement (TAVR) in clinical practice has widened options for symptomatic patients at high surgical risk; however, it is not known whether TAVR has equivalent or prolonged benefits in terms of le ...
Full textLink to itemCite
Journal ArticleGlobal Health · June 13, 2014
BACKGROUND: Mobile health (mHealth) approaches for non-communicable disease (NCD) care seem particularly applicable to sub-Saharan Africa given the penetration of mobile phones in the region. The evidence to support its implementation has not been critical ...
Full textOpen AccessLink to itemCite
Journal ArticleGlob Heart · June 2014
Studies have demonstrated strong associations between publication source and citations, as well as investigatory analysis of collaboration effects, in general and medical literature, but are limited to specific journals or short duration of time. This stud ...
Full textLink to itemCite
Journal ArticleGlob Heart · June 2014
BACKGROUND: Small observational studies have found that isolated right heart failure (IRHF) is prevalent among women of sub-Saharan Africa. Further, several risk factors for the development of IRHF have been identified. However, no similar studies have bee ...
Full textOpen AccessLink to itemCite
Journal ArticleBMC Infect Dis · May 22, 2014
BACKGROUND: Mortality among people with human immunodeficiency virus (HIV) infection is increasingly due to non-communicable causes. This has been observed mostly in developed countries and the routine care of HIV infected individuals has now expanded to i ...
Full textOpen AccessLink to itemCite
Journal ArticleTrials · April 27, 2014
Featured Publication
BACKGROUND: Hypertension is the leading global risk factor for mortality. Hypertension treatment and control rates are low worldwide, and delays in seeking care are associated with increased mortality. Thus, a critical component of hypertension management ...
Full textOpen AccessLink to itemCite
Journal ArticlePLoS One · 2014
Featured Publication
BACKGROUND: Trends in the prevalence of acute myocardial infarction in sub-Saharan Africa have not been well described, despite growing recognition of the increasing burden of cardiovascular disease in low- and middle-income countries. The aim of this syst ...
Full textOpen AccessLink to itemCite
Journal ArticleBMC Infectious Diseases · 2014
Featured Publication
Background: Mortality among people with human immunodeficiency virus (HIV) infection is increasingly due to non-communicable causes. This has been observed mostly in developed countries and the routine care of HIV infected individuals has now expanded to i ...
Full textCite
Chapter · November 1, 2013
A complete and accurate assessment of the aortic annulus and the surrounding structures is accomplished non-invasively by on organized echocardiographic approch employing a variety of techniques. An approch with transthoracic and transesophageal imaging mo ...
Full textCite
Journal ArticleHeart · September 2013
Featured Publication
OBJECTIVE: To describe the distribution of cardiovascular risk factors in western Kenya using a Health and Demographic Surveillance System (HDSS). DESIGN: Population based survey of residents in an HDSS. SETTING: Webuye Division in Bungoma East District, W ...
Full textLink to itemCite
Journal ArticleJ Hum Hypertens · July 2013
Featured Publication
The relationship between blood pressure (BP) and kidney function among individuals with chronic kidney disease (CKD) remains controversial. This study evaluated the association between BP and estimated glomerular filtration rate (eGFR) decline among adults ...
Full textLink to itemCite
Journal ArticleGlobal Health · May 16, 2013
Featured Publication
BACKGROUND: The burdens of hypertension and diabetes are increasing in low- and middle-income countries (LMICs). It is important to identify patients with these conditions early in the disease process. The goal of this study, therefore, is to compare commu ...
Full textLink to itemCite
Journal ArticleCurr Cardiol Rev · May 2013
Featured Publication
The heart failure syndrome has been recognized as a significant contributor to cardiovascular disease burden in sub-Saharan African for many decades. Seminal knowledge regarding heart failure in the region came from case reports and case series of the earl ...
Full textOpen AccessLink to itemCite
Journal ArticleJ Am Soc Echocardiogr · April 2013
Featured Publication
BACKGROUND: Multicenter clinical trials use echocardiographic core laboratories to ensure expertise and consistency in the assessment of imaging eligibility criteria, as well as safety and efficacy end points. The aim of this study was to report the real-w ...
Full textLink to itemCite
Journal ArticlePLoS One · 2013
Featured Publication
INTRODUCTION: Health research is one mechanism to improve population-level health and should generally match the health needs of populations. However, there have been limited data to assess the trends in national-level cardiovascular research output, even ...
Full textLink to itemCite
Journal ArticleGlob Heart · September 1, 2012
Featured Publication
The health effects of exposure to household air pollution are gaining international attention. While the bulk of the known mortality estimates due to these exposures are derived from respiratory conditions, there is growing evidence of adverse cardiovascul ...
Full textLink to itemCite
Journal ArticleJACC Cardiovasc Imaging · April 2012
Featured Publication
The advent of transcatheter aortic valve replacement (TAVR) is one of the most widely anticipated advances in the care of patients with severe aortic stenosis. This procedure is unique in many ways, one of which is the need for a multimodality imaging team ...
Full textLink to itemCite
Journal ArticleAm Heart J · May 2011
Featured Publication
Noncommunicable diseases are rapidly overtaking infectious, perinatal, nutritional, and maternal diseases as the major causes of worldwide death and disability. It is estimated that, within the next 10 to 15 years, the increasing burden of chronic diseases ...
Full textLink to itemCite
Journal ArticlePLoS One · 2011
Featured Publication
BACKGROUND: There is increased risk of cardiovascular disease among HIV seropositive individuals. The prevalence of HIV is highest in sub-Saharan Africa; however, HIV-related cardiovascular risk research is largely derived from developed country settings. ...
Full textOpen AccessLink to itemCite